Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Epilepsy D004827 35 associated lipids
Leukemia, Erythroblastic, Acute D004915 41 associated lipids
Escherichia coli Infections D004927 17 associated lipids
Extravasation of Diagnostic and Therapeutic Materials D005119 3 associated lipids
Fetal Growth Retardation D005317 9 associated lipids
Fever D005334 35 associated lipids
Fibrosis D005355 23 associated lipids
Gastritis D005756 27 associated lipids
Gastroesophageal Reflux D005764 10 associated lipids
Glioma D005910 112 associated lipids
Gliosis D005911 6 associated lipids
Glomerulonephritis D005921 35 associated lipids
Glomerulonephritis, IGA D005922 7 associated lipids
Rhinitis, Allergic, Seasonal D006255 7 associated lipids
Heart Arrest D006323 13 associated lipids
Heart Defects, Congenital D006330 20 associated lipids
Cardiomegaly D006332 31 associated lipids
Heart Injuries D006335 6 associated lipids
Hematoma, Subdural D006408 3 associated lipids
Hemolysis D006461 131 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Prunieras M Melanocytes, melanogenesis, and inflammation. 1986 Int. J. Dermatol. pmid:2433237
Schleimer RP et al. Selective inhibition of arachidonic acid metabolite release from human lung tissue by antiinflammatory steroids. 1986 J. Immunol. pmid:3082976
Viero P et al. Defective platelet aggregation induced by platelet activating factor in myeloproliferative disorders: deficiency of an aspirin-independent mechanism? 1986 Haemostasis pmid:3699584
Nunez D et al. Specific inhibition of PAF-acether-induced platelet activation by BN 52021 and comparison with the PAF-acether inhibitors kadsurenone and CV 3988. 1986 Eur. J. Pharmacol. pmid:3086108
Oxholm P and Winther K Thrombocyte involvement in immune inflammatory reactions. 1986 Allergy pmid:3515999
Wallace JL and Whittle BJ Picomole doses of platelet-activating factor predispose the gastric mucosa to damage by topical irritants. 1986 Prostaglandins pmid:3726156
DeFeudis FV Possible relationship between the syntheses of endothelium-derived relaxing factor (EDRF) and PAF-acether. 1986 Gen. Pharmacol. pmid:3516791
Eche N et al. Platelet aggregating and procoagulant activities of cultured human breast cancer cells (FAM). 1986 Thromb. Res. pmid:3726808
Camussi G Potential role of platelet-activating factor in renal pathophysiology. 1986 Kidney Int. pmid:3517457
Hoffman DR et al. The role of platelet-activating factor in human fetal lung maturation. 1986 Am. J. Obstet. Gynecol. pmid:3728606
Mastacchi R et al. Interaction of a new low molecular weight heparin (OP/LMWH) with human platelets. 1986 Agents Actions pmid:3518359
Simmet T and Peskar BA Eicosanoids and the coronary circulation. 1986 Rev. Physiol. Biochem. Pharmacol. pmid:3520775
Conrad GW and Rink TJ Platelet activating factor raises intracellular calcium ion concentration in macrophages. 1986 J. Cell Biol. pmid:3733874
Moudgil GC Anaesthesia and allergic drug reactions. 1986 Can Anaesth Soc J pmid:3521800
Imura Y et al. Possible role of platelet activating factor (PAF) in disseminated intravascular coagulation (DIC), evidenced by use of a PAF antagonist, CV-3988. 1986 Life Sci. pmid:3741541
Foegh ML et al. Prolongation of cardiac allograft survival with BN 52021, a specific antagonist of platelet-activating factor. 1986 Transplantation pmid:3523888
Kertscher HP and Ostermann G [Synthesis and thrombocyte aggregating action of stereoisomers of PAF-acether]. 1986 Pharmazie pmid:3786385
Rampart M and Williams TJ Polymorphonuclear leukocyte-dependent plasma leakage in the rabbit skin is enhanced or inhibited by prostacyclin, depending on the route of administration. 1986 Am. J. Pathol. pmid:3524253
Powling MJ and Hardisty RM Differential effects of 12-O-tetradecanoylphorbol 13-acetate on platelet responses to various agonists in the presence and absence of extracellular Ca2+. 1986 Thromb. Res. pmid:3787566
Siffert W et al. Inhibition of platelet aggregation by amiloride. 1986 Thromb. Res. pmid:3787567
Whittle BJ et al. Microvascular actions of platelet-activating factor on rat gastric mucosa and submucosa. 1986 Am. J. Physiol. pmid:3789144
Wardlaw AJ et al. Platelet-activating factor. A potent chemotactic and chemokinetic factor for human eosinophils. 1986 J. Clin. Invest. pmid:3023451
O'Flaherty JT et al. Metabolism of 5-hydroxyicosatetraenoate by human neutrophils: production of a novel omega-oxidized derivative. 1986 J. Immunol. pmid:3095426
O'Flaherty JT Age dependency of the inflammatory response. 1986 Lab. Invest. pmid:3537520
Touvay C et al. Inhibition of antigen-induced lung anaphylaxis in the guinea-pig by BN 52021 a new specific paf-acether receptor antagonist isolated from Ginkgo biloba. 1986 Agents Actions pmid:3754380
Sybertz EJ et al. AGEPC, a vasodilator phospholipid with profound circulatory actions. 1986 Prog. Clin. Biol. Res. pmid:3538024
Sugatani J and Hanahan DJ Characterization of 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine (AGEPC)-induced protein phosphorylation in rabbit platelets: inhibitory effects of AGEPC analogs. 1986 Arch. Biochem. Biophys. pmid:3754710
McGowan HM et al. Increased aortic PGI2 and plasma lyso-PAF in the unclipped one-kidney hypertensive rat. 1986 Am. J. Physiol. pmid:3538908
Hsueh W et al. Platelet activating factor-induced ischemic bowel necrosis: the effect of PAF antagonists. 1986 Eur. J. Pharmacol. pmid:3754817
Hemmendinger S et al. [Methods of studying platelet function. Biological markers of the activation of human platelets in vivo and in vitro]. 1986 Ann. Biol. Clin. (Paris) pmid:3538949
Okamoto M et al. Platelet activating factor (PAF) involvement in endotoxin-induced thrombocytopenia in rabbits: studies with FR-900452, a specific inhibitor of PAF. 1986 Thromb. Res. pmid:3754990
Zimmerman GA and Klein-Knoeckel D Human endothelial cells inhibit granulocyte aggregation in vitro. 1986 J. Immunol. pmid:3009611
Villamediana LM et al. Effects of the platelet-activating factor antagonist BN 52021 on the hemodynamics of rats with experimental cirrhosis of the liver. 1986 Life Sci. pmid:3755490
Garay R and Braquet P Involvement of K+ movements in the membrane signal induced by PAF-acether. 1986 Biochem. Pharmacol. pmid:3755602
Pfueller SL and David R Different platelet specificities of heparin-dependent platelet aggregating factors in heparin-associated immune thrombocytopenia. 1986 Br. J. Haematol. pmid:3756098
Hoffman DR et al. Cytotoxicity and metabolism of alkyl phospholipid analogues in neoplastic cells. 1986 Cancer Res. pmid:3756924
Sage SO and Rink TJ Effects of ionic substitution on [Ca2+]i rises evoked by thrombin and PAF in human platelets. 1986 Eur. J. Pharmacol. pmid:3758190
Chignard M et al. Use of steroidal antiinflammatory drug provides further evidence for a potential role of PAF-acether in bronchial anaphylaxis. 1986 Int. Arch. Allergy Appl. Immunol. pmid:3759260
Roubin R et al. Biosynthesis of paf-acether: VIII: Impairment of paf-acether production in activated macrophages does not depend upon acetyltransferase activity. 1986 J. Immunol. pmid:3950403
Ohno M et al. Molecular design toward biologically significant compounds based on platelet activating factor: a highly selective agonist as a potential antihypertensive agent. 1986 J. Med. Chem. pmid:3761300
Parnham MJ and Bittner C Pharmacological analysis of guinea-pig macrophage chemiluminescence responses to platelet activating factor and opsonized zymosan. 1986 Int. J. Immunopharmacol. pmid:3804536
Alloatti G et al. Effect of platelet-activating factor (PAF) on human cardiac muscle. 1986 Int. Arch. Allergy Appl. Immunol. pmid:3941007
Oh-ishi S et al. Suppression of phorbol myristate acetate-induced pleurisy by CV-3988, an antagonist of platelet-activating factor. 1986 Chem. Pharm. Bull. pmid:3829203
Handley DA et al. Vascular responses of platelet-activating factor in the Cebus apella primate and inhibitory profiles of antagonists SRI 63-072 and SRI 63-119. 1986 Immunopharmacology pmid:3733419
Ramesha CS and Pickett WC Measurement of sub-picogram quantities of platelet activating factor (AGEPC) by gas chromatography/negative ion chemical ionization mass spectrometry. 1986 Biomed. Environ. Mass Spectrom. pmid:2938649
Resink TJ et al. The influence of activating hormones on human platelet membrane Ca2+-ATPase activity. 1986 Biochem. Biophys. Res. Commun. pmid:2943273
Gay JC et al. Modulation of neutrophil oxidative responses to soluble stimuli by platelet-activating factor. 1986 Blood pmid:3006836
Stimler-Gerard NP Parasympathetic stimulation as a mechanism for platelet-activating factor-induced contractile responses in the lung. 1986 J. Pharmacol. Exp. Ther. pmid:3958964
Wade PJ et al. Effect of calcium and calcium antagonists on [3H]-Paf-acether binding to washed human platelets. 1986 Thromb. Res. pmid:3961730
Becker EL et al. Pertussis toxin as a probe of neutrophil activation. 1986 Fed. Proc. pmid:3011523
Ozaki Y et al. Oxygen radical production by neutrophils from patients with bacterial infection and rheumatoid arthritis. Measurement of hydrogen peroxide may most accurately represent enhancement of oxygen radical production during infection. 1986 Inflammation pmid:3011666
Schlondorff D et al. Different concentrations of pertussis toxin have opposite effects on agonist-induced PGE2 formation in mesangial cells. 1986 Biochem. Biophys. Res. Commun. pmid:3099783
Doebber TW et al. Platelet-activating factor (PAF) mediation of rat anaphylactic responses to soluble immune complexes. Studies with PAF receptor antagonist L-652,731. 1986 J. Immunol. pmid:3011900
Okayasu T et al. Metabolism of platelet-activating factor in primary cultured adult rat hepatocytes by a new pathway involving phospholipase C and alkyl monooxygenase. 1986 Biochim. Biophys. Acta pmid:3947669
Baranes J et al. The effects of PAF-acether on the cardiovascular system and their inhibition by a new highly specific PAF-acether receptor antagonist BN 52021. 1986 Pharmacol Res Commun pmid:3763677
Cirino M et al. A study with BN 52021 demonstrates the involvement of PAF-acether in IgE-dependent anaphylactic bronchoconstriction. 1986 Prostaglandins pmid:3763941
Wallace JL and Whittle BJ Profile of gastrointestinal damage induced by platelet-activating factor. 1986 Prostaglandins pmid:3763942
Bourgain RH et al. Thrombus induction by endogenic paf-acether and its inhibition by Ginkgo Biloba extracts in the guinea pig. 1986 Prostaglandins pmid:3763943
Guinot P et al. Inhibition of PAF-acether induced weal and flare reaction in man by a specific PAF antagonist. 1986 Prostaglandins pmid:3763944
Kikawa Y et al. Leukotriene B4 biosynthesis in polymorphonuclear leukocytes from blood of umbilical cord, infants, children, and adults. 1986 Pediatr. Res. pmid:3012451
Burhop KE et al. Platelet-activating factor increases lung vascular permeability to protein. 1986 J. Appl. Physiol. pmid:3804927
Bussolino F et al. Production of platelet-activating factor by chick retina. 1986 J. Biol. Chem. pmid:3023352
Cox CP Effects of CV-3988, an antagonist of platelet-activating factor (PAF), on washed rabbit platelets. 1986 Thromb. Res. pmid:2421432
Schleimer RP et al. Characterization of inflammatory mediator release from purified human lung mast cells. 1986 Am. Rev. Respir. Dis. pmid:3485946
Okamoto M et al. Studies of platelet activating factor (PAF) antagonists from microbial products. I. Bisdethiobis(methylthio)gliotoxin and its derivatives. 1986 Chem. Pharm. Bull. pmid:2421923
Okamoto M et al. Studies of platelet activating factor (PAF) antagonists from microbial products. II. Pharmacological studies of FR-49175 in animal models. 1986 Chem. Pharm. Bull. pmid:2421924
Herrmann DB et al. Ether phospholipids as inhibitors of the arachidonoyl-CoA: 1-acyl-sn-glycero-3-phosphocholine acyltransferase in macrophages. 1986 Biochim. Biophys. Acta pmid:3947667
Robertson DN and Smith GM CV3988 inhibits in vivo platelet aggregation induced by PAF-acether and collagen. 1986 Eur. J. Pharmacol. pmid:3709663
Darius H et al. Role of platelet-activating factor-acether in mediating guinea pig anaphylaxis. 1986 Science pmid:3082008
Kohayakawa M and Inoue K Augmentation of 1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine (PAF)-induced human platelet activation by C-reactive protein. 1986 Thromb. Res. pmid:3083530
Morley J et al. Effects of ketotifen upon responses to platelet activating factor: a basis for asthma prophylaxis. 1986 Ann Allergy pmid:3083731
McIntosh TK and Faden AI Thyrotropin-releasing hormone (TRH) and circulatory shock. 1986 Circ. Shock pmid:3084122
Bussolino F et al. Interleukin 1 stimulates platelet activating factor production in cultured human endothelial cells. 1986 Pharmacol Res Commun pmid:3490673
Ghezzi E Autacoids and some mediators in allergic and non allergic forms. 1986 Boll Ist Sieroter Milan pmid:2877678
Raphael GD and Metcalfe DD Mediators of airway inflammation. 1986 Eur J Respir Dis Suppl pmid:2429857
Yoshida J et al. A platelet-aggregating and hypotensive phospholipid isolated from bovine brain. 1986 J. Pharm. Pharmacol. pmid:2880959
Mehta J et al. Biphasic effects of platelet-activating factor on coronary blood flow in anesthetized dog. 1986 Prostaglandins Leukot Med pmid:3456620
McIntyre TM et al. Leukotrienes C4 and D4 stimulate human endothelial cells to synthesize platelet-activating factor and bind neutrophils. 1986 Proc. Natl. Acad. Sci. U.S.A. pmid:3457383
Di Marzo V et al. The effect of vasoactive intestinal peptide and calcitonin gene-related peptide on peptidoleukotriene release from platelet activating factor stimulated rat lungs and ionophore stimulated guinea pig lungs. 1986 Biochem. Int. pmid:2432897
Oh S et al. Inflammatory effects of acetylglycerylether phosphorylcholine: vascular permeability increase and induction of pleurisy in rats. 1986 Prostaglandins Leukot Med pmid:3459197
Ramesha CS and Pickett WC Metabolism of platelet-activating factor by arachidonic acid-depleted rat polymorphonuclear leukocytes. 1986 J. Biol. Chem. pmid:3096991
Newhouse MT and Sears MR Platelet activating factor, ketotifen and asthma. 1986 N. Z. Med. J. pmid:3462569
Chignard M et al. Direct evidence for the existence of a neutrophil-derived platelet activator (neutrophilin). 1986 Proc. Natl. Acad. Sci. U.S.A. pmid:3464972
Hahn HL et al. Effects of platelet activating factor on tracheal mucus secretion, on airway mechanics and on circulating blood cells in live ferrets. 1986 Eur J Respir Dis Suppl pmid:3465554
Morley J and Sanjar S Ketotifen and asthma. 1986 N. Z. Med. J. pmid:3466080
Page CP Platelet activating factor, ketotifen and asthma. 1986 N. Z. Med. J. pmid:3466093
Kloprogge E and Akkerman JW Platelet-activating factor (PAF-acether) induces high- and low-affinity binding of fibrinogen to human platelets via independent mechanisms. 1986 Biochem. J. pmid:3101672
Etienne A et al. Antithrombotic activity of BN 50341, a structurally new compound with anticalcic and PAF-antagonistic properties. 1986 Agents Actions Suppl. pmid:3468781
Bessin P PAF-acether and leukotriene participation in acute circulatory shock. 1986 Pharmacol Res Commun pmid:3774841
Goldstein RE et al. Coronary and pulmonary vascular effects of leukotrienes and PAF-acether. 1986 Pharmacol Res Commun pmid:3774842
Zimmerman GA et al. Thrombin stimulates neutrophil adherence by an endothelial cell-dependent mechanism: characterization of the response and relationship to platelet-activating factor synthesis. 1986 Ann. N. Y. Acad. Sci. pmid:3471149
Plante GE et al. Hemodynamic effects of PAF-acether. 1986 Pharmacol Res Commun pmid:3774843
Sanchez Crespo M et al. Evidence of a role for PAF-acether in the pathophysiology of the shock state. 1986 Pharmacol Res Commun pmid:3774844
Adnot S et al. Interference of BN 52021, a PAF-acether antagonist, with endotoxin-induced hypotension in the guinea-pig. 1986 Pharmacol Res Commun pmid:3774845
Rainsford KD Relative roles of leukotrienes and platelet activating factor in experimentally-induced gastric ulceration. 1986 Pharmacol Res Commun pmid:3774846
Page CP and Morley J Evidence favouring PAF rather than leukotrienes in the pathogenesis of asthma. 1986 Pharmacol Res Commun pmid:3774847
Haye-Legrand I et al. Production of PAF-acether and leukotrienes by cultured mouse macrophages. 1986 Pharmacol Res Commun pmid:3774848
Dupont L et al. Crystal and molecular structure of BN 52021, a PAF-acether antagonist. Comparison with the conformation of Kadsurenone and related compounds. 1986 Pharmacol Res Commun pmid:3774849
Bruynzeel PL et al. Platelet-activating factor (PAF-acether) induced leukotriene C4 formation and luminol dependent chemiluminescence by human eosinophils. 1986 Pharmacol Res Commun pmid:3774850
Lee TC et al. A new de novo pathway for the formation of 1-alkyl-2-acetyl-sn-glycerols, precursors of platelet activating factor. Biochemical characterization of 1-alkyl-2-lyso-sn-glycero-3-P:acetyl-CoA acetyltransferase in rat spleen. 1986 J. Biol. Chem. pmid:3007498